Telo Genomics Corp. announced that company's current CEO, Sherif Louis PhD, will assume the position of President & Chief Technology Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 CAD | -9.76% |
|
0.00% | -7.50% |
06-21 | Telo Genomics Corp. announced that it has received CAD 0.65 million in funding | CI |
06-18 | Telo Genomics' Myeloma Test Accepted as Lab Developed Test by College of American Pathologists | MT |
1st Jan change | Capi. | |
---|---|---|
-7.50% | 9.64M | |
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-1.35% | 2.24B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M |
- Stock Market
- Equities
- TELO Stock
- News Telo Genomics Corp.
- Telo Genomics Corp. Appoints Sherif Louis as President & Chief Technology Officer